FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693523013 | Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693525018 | Erythromycin 20 mg/g and isotretinoin 500 microgram/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 468776010 | Isotretinoin+erythromycin 0.05%/2% gel | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 468776010 | Isotretinoin+erythromycin 0.05%/2% gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 721658012 | Isotretinoin+erythromycin 0.05%/2% gel (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192737015 | Isotretinoin+erythromycin 0.05%/2% gel (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192737015 | Isotretinoin+erythromycin 0.05%/2% gel (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693523013 | Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693524019 | Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693525018 | Erythromycin 20 mg/g and isotretinoin 500 microgram/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing erythromycin in topical dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing isotretinoin (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Erythromycin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | agent cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Isotretinoin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing erythromycin and isotretinoin (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Bactericide | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | forme pharmaceutique pour usage transdermique et/ou cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Gel (basic dose form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Conventional release cutaneous gel (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing isotretinoin in topical dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Isotretinoin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Erythromycin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Isotretinoin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Erythromycin and isotretinoin only product in cutaneous dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Isotretinoin (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Erythromycin (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Isotretinoin (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets